Malaria Treatment Market is Growing Worldwide With Key Players Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Sanofi, GlaxoSmithKline plc, Pfizer Inc, Novartis AG, Mylan N.V

Global Malaria Treatment Market is having several developments, product launches, joint ventures, merges and accusations by its prominent market players and top brands which are driving the market in the terms of sales, import, export and revenue. This report gives an edge to not just compete but to outmatch the competition. The report provides with CAGR value fluctuation during the forecast period of 2019-2026 for the Malaria Treatment Market. This report also contains all the drivers and restrains with the help of SWOT analysis for the Global Malaria Treatment Market.

The report also holds it place when it comes detailed market definition, classifications, applications and market trends.

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-malaria-treatment-market

Global Malaria Treatment Market By Drugs Class (Artemisinin-Based Combination Therapies (ACTs), Chloroquine Phosphate, Vaccines and Others), Drugs (Mefloquine, Primaquine Phosphate, Quinine Sulfate, Artemether & Lumefantrine, Mosquirix and Others), Treatment (Medication, Supportive Care, Vaccination and Others), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026

Global malaria treatment market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of malaria in tropical and sub-tropical regions along with the rise in investment from government, public & private organizations for the development of novel drugs.

The key market players in the global malaria treatment market are Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Sanofi, GlaxoSmithKline plc, Pfizer Inc, Novartis AG, Mylan N.V, Teva Pharmaceutical Industries Ltd, Baxter, Amyris, Advanz Pharmaceutical, Lannett, Hikma Pharmaceuticals PLC, Zydus Cadila, Amneal Pharmaceuticals LLC, LUPIN, NATCO Pharma Limited, Ipca Laboratories Ltd, Alvogen among others.

Market Drivers

Increasing prevalence of malaria in tropical and sub-tropical regions is driving the market growth.

Increased government funding to fight against malaria is accelerating the market growth

Unmet market needs of managing malaria burden around the world is also boosting the market growth

Rise in medical insurance in developing countries is acting as catalyst in the growth of this market

Market Restraints

Lack or insufficient healthcare infrastructure in underdeveloped and developing regions is hampering the market growth

Lack of awareness related to symptoms of malaria in developing countries also restricts the market growth

Market Definition:

Plasmodium parasites are the main causative reason for malaria infection. When the female Anopheles mosquitoes, already carrying the parasite bites the humans, the parasite is released into the bloodstream than they travel to the liver, where their maturation occurs, before they enter the the bloodstream and begin to infect the RBC. After 48 to 72 hours of infection, the parasites inside the red blood cells multiply, causing the infected cells to burst open resulting in symptoms such as chills, fever and sweating that occur in cycles that last two to three days at a time. According to W.H.O, in 2017 there were an estimated 219 million cases of malaria in 87 countries and deaths stood at 435 000. African Region had the highest prevalent rate of malaria in 2017; the region was home to 92% of malaria cases and 93% of malaria deaths

Order a Copy of Global Malaria Treatment Market Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-malaria-treatment-market

Segmentation: Global Malaria Treatment Market

By Drugs Class

Artemisinin-Based Combination Therapies (ACTs)
Chloroquine Phosphate
Vaccines
Others

By Drugs

Mefloquine
Primaquine Phosphate
Quinine Sulfate
Artemether & Lumefantrine
Mosquirix
Others

By Treatment

Medication
Supportive Care
Vaccination
Others

By Route of Administration

Oral
Parenteral

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By End-Users

Hospitals
Homecare
Specialty Clinics

By Geography

North America
Europe
Asia-Pacific
South America
Middle East & Africa
South Africa
Rest of Middle East & Africa

Key Developments in the Market

In April 2019, La Jolla Pharmaceutical Company received the U.S FDA Breakthrough Therapy designation for LJPC-0118, an investigational drug for the treatment of severe malaria. This designation is a key regulatory milestone for the company and it will help the company to work closely with the U.S FDA for the further development of the drug

In July 2018, GlaxoSmithKline plc received the U.S FDA approval for tafenoquine (Krintafel) for the "radical cure" of Plasmodium vivax malaria in patients aged more than 16 years, who are receiving antimalarial therapy for acute infection. This was the new medicine approved after decades to counter P. vivax malaria relapse and to provide potential treatment for vulnerable patients that need it most

Competitive Analysis:

Global malaria treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of malaria treatment for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

Current and future of global malaria treatment market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents:

Introduction
Market Segmentation
Market Overview
Executive Summary
Premium Insights
Global, By Component
Product Type
Delivery
Industry Type
Geography
Company Landscape
Company Profiles
Related Reports

Access Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-malaria-treatment-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.